Bio-Techne Corp (TECH) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Bio-techne Corp.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.858 -- 00:00:05.822 Good morning, and welcome to the Biotechni Earnings Conference call for the second quarter 00:00:05.822 -- 00:00:11.027 of fiscal year 2025. At this time, all participants have been placed in 00:00:11.027 -- 00:00:15.531 a listen-only mode, and the call will be open for questions following management's prepared 00:00:15.531 -- 00:00:17.012 remarks. 00:00:17.012 -- 00:00:22.597 During our Q&A session, please limit yourself to one question and one follow-up. 00:00:22.597 -- 00:00:26.741 I would now like to turn the call over to David Clare, Biotechni's Vice President and 00:00:26.741 -- 00:00:28.863 Best of Relations. 00:00:28.863 -- 00:00:31.418 Good morning, and thank you for joining us. 00:00:31.418 -- 00:00:36.505 On the call with me this morning are Kim Kelderman, President and Chief Executive Officer, 00:00:36.505 -- 00:00:40.370 and Jim Hippel, Chief Financial Officer of Biotechni. 00:00:40.370 -- 00:00:43.734 Before we begin, let me briefly cover our safe harbor statement. 00:00:43.734 -- 00:00:47.319 Some of the comments made during this conference call may be considered forward-looking 00:00:47.319 -- 00:00:52.766 statements, including beliefs and expectations about the company's future results. 00:00:52.766 -- 00:00:57.993 The company's 10-K for fiscal year 2024 identifies certain factors that could cause 00:00:57.993 -- 00:01:03.020 the company's actual results, to differ materially from those projected in the forward-looking 00:01:03.020 -- 00:01:06.064 statements made during this call. 00:01:06.064 -- 00:01:10.368 The company does not undertake to update any forward-looking statements because of any 00:01:10.368 -- 00:01:13.612 new information or future events or developments. 00:01:13.612 -- 00:01:18.958 The 10-K, as w...